Patents by Inventor Gert Hoy

Gert Hoy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160053318
    Abstract: The present invention provides markers of endothelial progenitor cells (EPCs) and use of those markers and reagents that bind thereto to detect EPC cells or diagnose, prognose, treat or prevent EPC-associated conditions.
    Type: Application
    Filed: September 4, 2015
    Publication date: February 25, 2016
    Applicant: Medvet Science Pty Ltd.
    Inventors: CLAUDINE SHARON BONDER, Angel Francisco Lopez, Gert Hoy Talbo
  • Publication number: 20140350120
    Abstract: A substantially anhydrous topical composition comprises a homogenous mixture of (a) a therapeutically effective amount of an ingenol derivative in dissolved form; (b) an oily solvent for the ingenol derivative, (c) an acidic compound, and (d) optionally a pharmaceutically acceptable non-solvent lipid carrier.
    Type: Application
    Filed: December 12, 2012
    Publication date: November 27, 2014
    Applicant: Leo Laboratories Limited
    Inventors: Per Ola Arvidsson, Edit Farkas, Karsten Petersson, Gert Hoy
  • Publication number: 20140350101
    Abstract: Substantially anhydrous topical gel compositions comprising a homogeneous mixture of: (a) ingenol-3-angelate in dissolved form; and (b) anon-aqueous carrier.
    Type: Application
    Filed: December 12, 2012
    Publication date: November 27, 2014
    Inventors: Per Ola Arvidsson, Edit Farkas, Karsten Petersson, Gert Hoy
  • Publication number: 20140348905
    Abstract: The present invention relates to a topical gel composition comprising ingenol-3-angelate, wherein the composition provides greater flux, according to the in vitro diffusion test, of ingenol-3-angelate into the stratum corneum, epidermis and dermis after application of the gel composition to skin than does a reference gel of ingenol-3-angelate, namely the PICATO® product.
    Type: Application
    Filed: December 12, 2012
    Publication date: November 27, 2014
    Inventors: Per Ola Arvidsson, Edit Farkas, Karsten Petersson, Gert Hoy
  • Publication number: 20140322310
    Abstract: Topical gel compositions comprising ingenol-3-angelate, wherein less than 10% of the ingenol-3-angelate degrades when the gel is stored for 2 years at 25° C.
    Type: Application
    Filed: December 12, 2012
    Publication date: October 30, 2014
    Inventors: Per Ola Arvidsson, Edit Farkas, Karsten Petersson, Gert Hoy
  • Publication number: 20130224116
    Abstract: The present invention provides markers of endothelial progenitor cells (EPCs) and use of those markers and reagents that bind thereto to detect EPC cells or diagnose, prognose, treat or prevent EPC-associated conditions.
    Type: Application
    Filed: November 7, 2011
    Publication date: August 29, 2013
    Applicant: TransBio Ltd.
    Inventors: Claudine Sharon Bonder, Angel Fransciso Lopez, Gert Hoy Talbo
  • Patent number: 7456148
    Abstract: A method for producing an anticoagulation effect in a blood coagulation assay, said method comprising contacting a sample of blood with an effective amount of apolipoprotein CIII or fragment, derivative, homologue, analogue, chemical equivalent, functional equivalent or mimetic thereof.
    Type: Grant
    Filed: July 23, 2004
    Date of Patent: November 25, 2008
    Assignee: Healthlinx Limited
    Inventors: Dominic J. Autelitano, Michael C. Berndt, Antonio Rajic, A. Ian Smith, Gert Hoy Talbo
  • Patent number: 6787529
    Abstract: The present invention relates to a pharmaceutical gel composition for application on skin, said composition comprising at least one vitamin D or vitamin D analogue and at least one corticosteroid as well as a viscosity-increasing excipient.
    Type: Grant
    Filed: October 26, 2001
    Date of Patent: September 7, 2004
    Assignee: Leo Pharmaceutical Products Ltd. A/S
    Inventors: Gert Høy, Erik Johannes Didriksen
  • Patent number: 6753013
    Abstract: A pharmaceutical composition for dermal use, wherein the composition has a first pharmacologically active component A consisting of at least one vitamin D or vitamin D analogue, and a second pharmacologically active component B consisting of at least one corticosteroid, wherein the difference between the maximum stability pH of said first component A and the maximum stability pH of said second component B is at least 1.
    Type: Grant
    Filed: October 22, 2001
    Date of Patent: June 22, 2004
    Assignee: Leo Pharmaceutical Products, Ltd. A/S
    Inventors: Erik Didriksen, Gert Høy
  • Publication number: 20030195150
    Abstract: The present invention provides antimicrobial peptides. The peptides are non-glycosylated, less than about 100 amino acids in length, and include an amino acid sequence selected from: AVESTVATLEA&Sgr;PEVIESPPE (SEQ ID NO:3), AVESTVATLED&Sgr;PEVIESPPE (SEQ ID NO:4), AVESTVATLEASPEVIESPPE (SEQ ID NO:5), AVESTVATLEDSPEVIESPPE (SEQ ID NO:6), DMPIQAFLLYQQPVLGPVR (SEQ ID NO:7), and conservative substitutions therein. These peptides can be produced synthetically; however, they can most conveniently be derived from casein.
    Type: Application
    Filed: October 24, 2002
    Publication date: October 16, 2003
    Inventors: Eric Charles Reynolds, Stuart Geoffrey Dashper, Neil Martin O'Brien-Simpson, Gert Hoy Talbo, Marina Malkoski
  • Publication number: 20020111336
    Abstract: The present invention relates to a pharmaceutical gel composition for application on skin, said composition comprising at least one vitamin D or vitamin D analogue and at least one corticosteroid as well as a viscosity-increasing excipient.
    Type: Application
    Filed: October 26, 2001
    Publication date: August 15, 2002
    Inventors: Gert Hoy, Erik Johannes Didriksen